Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07118579
PHASE4

Effects of Remimazolam and Ciprofol TIVA on PRAE in Pediatric Tonsillectomy and Adenoidectomy

Sponsor: Tongji Hospital

View on ClinicalTrials.gov

Summary

To observe the effects of remimazolam versus ciprofol TIVA on PRAE in pediatric tonsillectomy and adenoidectomy.

Official title: Effects of Remimazolam and Ciprofol Total Intravenous Anesthesia on Perioperative Respiratory Adverse Events in Pediatric Tonsillectomy and Adenoidectomy: A Randomized Controlled Study

Key Details

Gender

All

Age Range

2 Years - 12 Years

Study Type

INTERVENTIONAL

Enrollment

114

Start Date

2025-09-23

Completion Date

2026-08

Last Updated

2025-11-21

Healthy Volunteers

No

Interventions

DRUG

Remimazolam

remimazolam induction (0.3-0.5 mg/kg) + maintenance (1-3 mg/kg/h)

DRUG

Propofol

Anesthesia induction (2-3 mg/kg) + Anesthesia maintenance (6-10 mg/kg/h)

DRUG

Ciprofol

Anesthesia induction (0.4-0.5 mg/kg) + Anesthesia maintenance (0.8-1.2 mg/kg/h)

Locations (1)

Tongji Hospital

Wuhan, Hubei, China